DocDollars

Lilly USA, LLC

IN · United States · Reporting entity ID 100000000066

Total reported 2019–2025
$279.0M
#48 of 2,960 reporting companies — 0.3% of all reported industry payments
$257.7M in general payments across 2,688,469 records, plus $21.3M in research funding across 172 records.

How it breaks down

General payments $257,701,975
Research funding $21,328,515

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Lilly USA, LLC reported $279.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #48 of 2,960 reporting companies. 8% of that was research funding and 92% general payments such as consulting, speaking, food and travel. 2,688,469 general payment records and 172 research records were filed.

Common questions about Lilly USA, LLC

How much has Lilly USA, LLC paid US doctors?

Lilly USA, LLC reported $279,030,490 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $257,701,975 in general payments, $21,328,515 in research funding.

How does Lilly USA, LLC rank among drug and device companies?

It ranks #48 of 2,960 reporting entities by total reported value, about 0.3% of all industry payments in the dataset.

Does a payment from Lilly USA, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.